Search Tag: 3D Mammography

IMAGING Management

KLAS Report Shows Hologic Continuing to Lead the U.S. Breast Tomosynthesis Market

2016 15 Jun

Mammography customers highlight Hologic's high image quality, strong customer support, and market-leading product innovationsHologic (NASDAQ: HOLX) has announced that the Company received top marks from U.S. mammography providers in a new independent report from KLAS Research, with 96 percent of customers reporting that Hologic systems are worth the... Read more

IMAGING Management

Sheryl Crow is Hologic's National Celebrity Spokesperson for New Breast Cancer Educational Campaign

2016 02 Jun

Award-winning performer and breast cancer survivor to educate women about early detection and the Genius™ 3D MAMMOGRAPHY™ examHologic, Inc. (NASDAQ: HOLX) has announced that nine-time Grammy award-winning singer, songwriter and breast cancer survivor Sheryl Crow will serve as national spokesperson to educate women about a more accurate mammogram, the... Read more

IMAGING Management

Hologic to Webcast Presentations at Upcoming Investor Conferences

2016 04 May

Hologic, Inc. (Nasdaq: HOLX) has announced that the Company will present at these upcoming investor conferences:The Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, NV on Tuesday, May 10 at 11:20 am Pacific Time (PT) /2:20 pm Eastern Time (ET).The UBS Global Healthcare Conference in New York, NY on Tuesday, May 24 at 10 am ET Read more

IMAGING Management

Hologic Announces Financial Results for Second Quarter of Fiscal 2016

2016 28 Apr

- GAAP Diluted EPS of $0.24 Increases 41.2%, Non-GAAP Diluted EPS of $0.47 Increases 14.6% -- Revenue of $693.3 Million Grows 5.8% on a Reported Basis, 6.3% in Constant Currency -- Company Redeploys $460.2 Million of Capital to Reduce Convertible Debt, and Repurchase Shares -Hologic, Inc. (Nasdaq: HOLX) has announced the Company's financial results... Read more

IMAGING Management

JAMA Conclude that 3D MAMMOGRAPHY™ Exams Outperform Conventional Mammography

2016 27 Apr

Reducing Recall Rate for Breast Cancer Screening Stands to Decrease Healthcare Costs and Increase Quality of Care for WomenHologic, Inc. (Nasdaq: HOLX) has announced that study results published today in a research letter in JAMA conclude that breast tomosynthesis (Hologic's Genius™ 3D MAMMOGRAPHY™) exams reduce recall rates, and increase invasive cancer... Read more

IMAGING Management

Hologic Announces FDA Clearance and Commercial Availability of the Affirm™ Prone Biopsy System

2016 21 Apr

New System Pairs 360-Degree Breast Access with Exceptional 2D/3D™ Biopsy ImagingHologic, Inc. (Nasdaq: HOLX) has announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm™ prone biopsy system, the first dedicated prone biopsy system to offer both 2D and 3D™ imaging-guided breast biopsies."At Hologic, we challenge... Read more

Health Management

Another Big First For Hologic

2016 25 Aug

2D/3D Imaging on a Dedicated Prone Breast Biopsy System   Breast tomosynthesis imaging, Hologic calls it 3D mammography™, is ‏proving to be the best modality for breast cancer imaging. The Hologic ‏tomosynthesis system has demonstrated superior clinical performance ‏to conventional 2D mammography in a number of metrics, in particular ‏showing improved... Read more

IMAGING Management

3D Of Dense Breasts To Help Slash Recall Rate, Cost For Cancer Screening

2016 28 Apr

Breast tomosynthesis exams, combined with conventional mammography, can help reduce recall rates, and increase invasive cancer detection in women with both dense and non-dense breasts, according to research published in the Journal of the American Medical Association. These key benefits could lower the costs associated with needless follow-up exams,... Read more

Endorsed Companies